Related references
Note: Only part of the references are listed.Caloric restriction mimetics for the treatment of cardiovascular diseases
Sebastiano Sciarretta et al.
CARDIOVASCULAR RESEARCH (2021)
Nicotinamide for the treatment of heart failure with preserved ejection fraction
Mahmoud Abdellatif et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction
Dan Tong et al.
CIRCULATION RESEARCH (2021)
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Mihoko Yoshino et al.
SCIENCE (2021)
Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide
Tetsuo Horimatsu et al.
CARDIOVASCULAR RESEARCH (2020)
Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans
Carlijn M E Remie et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2020)
Boosting NAD level suppresses inflammator activation of PBMCs in heart failure
Bo Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures
Yasir S. Elhassan et al.
CELL REPORTS (2019)
A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects
Ole L. Dollerup et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2018)
Quantitative Analysis of NAD Synthesis-Breakdown Fluxes
Ling Liu et al.
CELL METABOLISM (2018)
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Jun Yoshino et al.
CELL METABOLISM (2018)
De novo NAD+ biosynthetic impairment in acute kidney injury in humans
Ali Poyan Mehr et al.
NATURE MEDICINE (2018)